CLOSE
CLOSE
Wright Medical Group, Inc.
Search
Investor Relations
And information
HomeInvestor Relations › Press Releases

Press Releases

Webcast ImageWebcast
Q2 2017 Wright Medical Group N.V. Earnings Conference Call (Live)
August 2, 2017 at 3:30 p.m. CT
Keyword Search
 
All News Releases | Earnings Releases | Corporate | Human Resources | Product
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004
DateTitle 
12/30/13 Tornier to Present at 32nd Annual J.P. Morgan Healthcare Conference
AMSTERDAM, The Netherlands, Dec. 30, 2013 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will present at the 32nd Annual J.P. Morgan Healthcare Conference. The Company's presentation is scheduled for Tuesday, January 14, 2014 at 11:00 a.m. Pa... 
Printer Friendly Version
12/18/13Wright Medical Group, Inc. to Participate in 32nd Annual J.P. Morgan Healthcare Conference
Monday, January 13, 2014 at 2:30 p.m. Pacific Time ARLINGTON, Tenn.--(BUSINESS WIRE)--Dec. 18, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) announced today that it will be participating in the 32nd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2014, at the Westin St. Francis Hotel in San Francisco, California. Robert Palmisano, president and chief executive officer, will present at 2:30 p.m. Pacific Time. A live a... 
Printer Friendly Version
12/16/13Wright Medical Group, Inc. Provides Date of MicroPort Shareholder Meeting to Approve Acquisition of Wright’s OrthoRecon Business
ARLINGTON, Tenn.--(BUSINESS WIRE)--Dec. 16, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) today reported it has been advised by MicroPort Scientific Corporation (HK: 0853) that the Hong Kong Stock Exchange has granted clearance of the disclosure circular required in connection with its shareholder meeting to approve the acquisition of Wright’s OrthoRecon business, and that MicroPort has, accordingly, scheduled a shareholder meeting to approve the tran... 
Printer Friendly Version
11/20/13Tornier to Present at Piper Jaffray 25th Annual Healthcare Conference
AMSTERDAM, Nov. 20, 2013 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will present at the Piper Jaffray 25th Annual Healthcare Conference. The Company will participate in a fireside chat presentation that is scheduled for Tuesday, December ... 
Printer Friendly Version
11/15/13Wright Medical Group, Inc. Completes Acquisition of Biotech International
ARLINGTON, Tenn.--(BUSINESS WIRE)--Nov. 15, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it has completed its acquisition of Biotech International (Biotech), a leading French orthopaedic extremities company. The transaction will significantly expand Wright’s direct sales channel in France and international distribution network and add Biotech’s complementary extremity product portfolio to further accelerate growth opportunities ... 
Printer Friendly Version
11/12/13Wright Medical Group, Inc. to Participate in 25th Annual Piper Jaffray Healthcare Conference
Tuesday, December 3, 2013 at 10:00 a.m. Eastern Time ARLINGTON, Tenn.--(BUSINESS WIRE)--Nov. 12, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) announced today that it will be participating in the 25th Annual Piper Jaffray Healthcare Conference on Tuesday, December 3, 2013, at the New York Palace Hotel in New York, New York. Robert Palmisano, president and chief executive officer, will present at 10:00 a.m. Eastern Time. A live audio... 
Printer Friendly Version
11/05/13Tornier Reports Third Quarter 2013 Results
U.S. distribution channel transition accelerates with agreements covering 61% of U.S. revenue Non-GAAP gross margin improved to 74.2% Aequalis Ascend Flex™ launch tracking to plan; over 120 trained surgeon usersAMSTERDAM, The Netherlands, Nov. 5, 2013 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported today its financial results for the third quarter ended September 29, 2013. Reven... 
Printer Friendly Version
11/04/13Wright Medical Group, Inc. Reports 2013 Third Quarter Financial Results
Global Foot and Ankle Net Sales Increase 21% As Reported and 22% Constant Currency Third Quarter Sales from Continuing Operations Increase 13% As Reported and 14% Constant Currency ARLINGTON, Tenn.--(BUSINESS WIRE)--Nov. 4, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) today reported financial results for its third quarter ended September 30, 2013. As a result of the previously announced agreement to sell the hip and knee business t... 
Printer Friendly Version
10/28/13Wright Medical Group, Inc. to Participate in Credit Suisse 2013 Healthcare Conference
Thursday, November 14, 2013 at 8:00 a.m. Mountain Time ARLINGTON, Tenn.--(BUSINESS WIRE)--Oct. 28, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) announced today that it will be participating in the Credit Suisse 2013 Healthcare Conference on Thursday, November 14, 2013, at The Phoenician in Scottsdale, Arizona. Robert Palmisano, president and chief executive officer, will present at 8:00 a.m. Mountain Time. A live audio webcast of t... 
Printer Friendly Version
10/16/13Wright Medical Group, Inc. Announces Definitive Agreement to Acquire Biotech International
Transaction Significantly Extends Reach of International Distribution Network to Further Accelerate Growth Opportunities in Wright’s Global Extremities Business Upfront Purchase Price Payment of $75 Million in Cash and Stock Plus Contingent Payments of up to $5 Million ARLINGTON, Tenn.--(BUSINESS WIRE)--Oct. 16, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) announced today that it has entered into a definitive agreement to a... 
Printer Friendly Version
10/10/13Tornier Announces Third Quarter 2013 Conference Call
AMSTERDAM, Oct. 10, 2013 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the third quarter ended September 29, 2013 after the close of the regular trading market on Tuesday, November 5, 2013. The Company also announced that it will host an investor conference call to discuss the results on the same day at 4:30 PM Eastern Time.Torn... 
Printer Friendly Version
10/03/13Wright Medical Group, Inc. to Host Third Quarter 2013 Earnings Conference Call
Monday, November 4, 2013 at 3:30 p.m. Central / 4:30 p.m. Eastern ARLINGTON, Tenn.--(BUSINESS WIRE)--Oct. 3, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it will host a conference call on Monday, November 4, 2013 at 3:30 p.m. Central Time to discuss the Company’s operating results for its third quarter ended September 30, 2013. Operating results will be released at 3:00 p.m. Central Time that day. The live dial... 
Printer Friendly Version
08/21/13Wright Medical Group, Inc. to Participate in Baird 2013 Health Care Conference
Wednesday, September 11, 2013 at 11:25 a.m. Eastern Time ARLINGTON, Tenn.--(BUSINESS WIRE)--Aug. 21, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) announced today that it will be participating in the Baird 2013 Health Care Conference on Wednesday, September 11, 2013, at the New York Palace Hotel in New York, New York. Lance Berry, chief financial officer, will present at 11:25 a.m. Eastern Time. A live audio webcast of the conferenc... 
Printer Friendly Version
08/20/13Wright Medical Group, Inc. to Participate in Morgan Stanley Global Healthcare Conference
Tuesday, September 10, 2013 at 8:35 a.m. Eastern Time ARLINGTON, Tenn.--(BUSINESS WIRE)--Aug. 20, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) announced today that it will be participating in the Morgan Stanley Global Healthcare Conference on Tuesday, September 10, 2013, at the Grand Hyatt Hotel in New York, New York. Robert Palmisano, president and chief executive officer, will present at 8:35 a.m. Eastern Time. A live audio webca... 
Printer Friendly Version
08/08/13Wright Medical Group, Inc. Announces Receipt of FDA Not Approvable Letter for Augment® Bone Graft
Company to Host Conference Call at 3:30 p.m. Central Time Today ARLINGTON, Tenn.--(BUSINESS WIRE)--Aug. 8, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) today announced it received a not approvable letter from the Food & Drug Administration (FDA) in response to its Pre-Market Approval (PMA) application for Augment® Bone Graft for use as an alternative to autograft in hindfoot and ankle fusion procedures. In the letter, FDA states it... 
Printer Friendly Version
08/06/13Tornier Reports Second Quarter 2013 Results
Achieves Double-Digit Upper Extremity Product Category Growth Improves Non-GAAP Gross Margin Sequentially and Quarter over Quarter to 73.9%Expands OrthoHelix Product Line Reach with First International SaleAMSTERDAM, Aug. 6, 2013 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremities specialists, reported today its financial results for the second quarter ended June 30, 2013. Revenue for the second quarte... 
Printer Friendly Version
08/05/13Wright Medical Group, Inc. Reports 2013 Second Quarter Financial Results
Global Foot and Ankle Net Sales Increase 29% As Reported and 30% Constant Currency Second Quarter Sales from Continuing Operations Increase 17% As Reported and 17% Constant Currency ARLINGTON, Tenn.--(BUSINESS WIRE)--Aug. 5, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) today reported financial results for its second quarter ended June 30, 2013. As a result of the previously announced agreement to sell the hip and knee business to ... 
Printer Friendly Version
07/17/13Wright Medical Group, Inc. Highlights New Innovations at the American Orthopaedic Foot and Ankle Society (AOFAS) Annual Meeting 2013
Announces U.S. Commercial Launch of ORTHOLOC® 3Di Ankle Fusion System ARLINGTON, Tenn.--(BUSINESS WIRE)--Jul. 17, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) today announced the U.S. commercial launch of the ORTHOLOC® 3Di Ankle Fusion System at the American Orthopaedic Foot and Ankle Society (AOFAS) Annual Meeting 2013 taking place at the Westin Diplomat in Hollywood, Florida from July 17-20, 2013. Offering six unique plate... 
Printer Friendly Version
07/15/13Tornier Announces Second Quarter 2013 Conference Call
July 15, 2013AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the second quarter ended June 30, 2013 after the market close on Tuesday, August 6, 2013. The Company also announced that it will host an investor conference call to discuss the results on the same day at 4:30 PM Eastern Time. Tornier invites all interested pa... 
Printer Friendly Version
07/09/13Wright Medical Group, Inc. to Host Second Quarter 2013 Earnings Conference Call
Monday, August 5, 2013 at 3:30 p.m. Central / 4:30 p.m. Eastern ARLINGTON, Tenn.--(BUSINESS WIRE)--Jul. 9, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it will host a conference call on Monday, August 5, 2013 at 3:30 p.m. Central Time to discuss the Company’s operating results for its second quarter ended June 30, 2013. Operating results will be released at 3:00 p.m. Central Time that day. The live dial-in numb... 
Printer Friendly Version
06/19/13Wright Medical Group, Inc. and MicroPort Scientific Corporation Enter Into Definitive Agreement Under Which MicroPort Will Acquire Wright’s OrthoRecon Business
Transaction Transforms Wright Medical into High Growth Extremities and Biologics Pure Play and Expands Growth Opportunities for OrthoRecon Business Purchase Price of $290 Million Cash Wright to Host Conference Call Thursday, June 20, 2013, at 8:00 a.m. Central Time ARLINGTON, Tenn.--(BUSINESS WIRE)--Jun. 19, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) today announced a definitive agreement under which MicroP... 
Printer Friendly Version
05/22/13Wright Medical Group, Inc. to Participate in Jefferies 2013 Global Healthcare Conference
Wednesday, June 5, 2013 at 8:00 a.m. Eastern Time ARLINGTON, Tenn.--(BUSINESS WIRE)--May. 22, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) announced today that it will be participating in the Jefferies 2013 Healthcare Conference on Wednesday, June 5, 2013, at the Grand Hyatt Hotel in New York City, New York. Lance Berry, chief financial officer, will present at 8:00 a.m. Eastern Time. A live audio webcast of the conference presenta... 
Printer Friendly Version
05/15/13Tornier Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters' Over-Allotment Option
May 15, 2013AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today the closing of the previously announced underwritten public offering of 8.05 million ordinary shares at a public offering price of $16.15 per ordinary share. The shares sold include 1.05 million ordinary shares sold pursuant to the option to purchase additional shares granted by Tornier and certain exi... 
Printer Friendly Version
05/14/13Wright Medical Group, Inc. Appoints Douglas G. Watson to Board of Directors
ARLINGTON, Tenn.--(BUSINESS WIRE)--May. 14, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that its shareholders have approved a proposal increasing the size of Wright’s Board of Directors to ten and have elected Douglas G. Watson as Wright Medical’s tenth Director, effective immediately. Mr. Watson is currently the Chief Executive Officer of Pittencrieff Glen Associates, a leadership and consulting firm that he founded in 1999.... 
Printer Friendly Version
05/09/13Tornier Announces Pricing of Public Offering of Ordinary Shares
May 9, 2013AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today the pricing of a previously announced underwritten registered public offering of 7.0 million ordinary shares at a public offering price of $16.15 per ordinary share. The offering is expected to close on or about May 15, 2013. Of the 7.0 million ordinary shares being sold in the offering, 4.5 million sh... 
Printer Friendly Version
05/07/13Tornier Reports First Quarter 2013 Results
May 7, 2013Reiterates Revenue and Non-GAAP Adjusted EBITDA Outlook for 2013 Non-GAAP Adjusted Gross Margin Expands 200 Basis Points Year over Year, Excluding Acquisition Related Costs AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported today its financial results for the first quarter ended March 31, 2013. Revenue for the first quarter of 2013 reached $82.7 million compar... 
Printer Friendly Version
05/07/13Tornier Announces Follow-on Offering of Ordinary Shares
Maay 7, 2013AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it has commenced an underwritten public offering of 7.0 million ordinary shares. Of the ordinary shares being offered for sale in the offering, Tornier is offering 4.5 million shares and certain existing shareholders are offering 2.5 million shares. The selling shareholders include funds associate... 
Printer Friendly Version
04/30/13Wright Medical Group, Inc. Reports 2013 First Quarter Financial Results
First Quarter Global Foot and Ankle Net Sales Increase 18% As Reported and 19% Constant Currency ARLINGTON, Tenn.--(BUSINESS WIRE)--Apr. 30, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) today reported financial results for its first quarter ended March 31, 2013. Net sales totaled $120.4 million during the first quarter ended March 31, 2013, representing a 5% decrease as reported and a 3% decrease on a constant currency basis compar... 
Printer Friendly Version
04/26/13Tornier to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
April 26, 2013AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will be presenting at the Bank of America Merrill Lynch 2013 Health Care Conference. The Company's presentation is scheduled for Wednesday, May 15, at 2:20 p.m. Pac... 
Printer Friendly Version
04/24/13Wright Medical Group, Inc. to Participate in Bank of America Merrill Lynch Healthcare Conference
Wednesday, May 15, 2013 at 1:40 p.m. Pacific Time ARLINGTON, Tenn.--(BUSINESS WIRE)--Apr. 24, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) announced today that it will be participating in the Bank of America Merrill Lynch Healthcare Conference on Wednesday, May 15, 2013, at the Encore at the Wynn Hotel in Las Vegas, Nevada. Lance Berry, chief financial officer, will present at 1:40 p.m. Pacific Time. A live audio webcast of the con... 
Printer Friendly Version
04/09/13Wright Medical Group, Inc. to Host First Quarter 2013 Earnings Conference Call
Tuesday, April 30, 2013 at 3:30 p.m. Central / 4:30 p.m. Eastern ARLINGTON, Tenn.--(BUSINESS WIRE)--Apr. 9, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it will host a conference call on Tuesday, April 30, 2013 at 3:30 p.m. Central Time to discuss the Company’s operating results for its first quarter ended March 31, 2013. Operating results will be released at 3:00 p.m. Central Time that day. The live dial-in nu... 
Printer Friendly Version
04/03/13Tornier Announces First Quarter 2013 Conference Call
April 3, 2013AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the first quarter ended March 31, 2013 after the market close on Tuesday, May 7, 2013. The Company also announced that it will host an investor conference call to discuss the results on the same day at 4:30 PM Eastern Time. Tornier invites all interested part... 
Printer Friendly Version
03/05/13Wright Medical Group, Inc. to Participate in Canaccord Genuity Musculoskeletal Conference
Tuesday, March 19, 2013 at 11:40 a.m. Central Time ARLINGTON, Tenn.--(BUSINESS WIRE)--Mar. 5, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) announced today that it will be participating in the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 19, 2013, at the Westin Michigan Avenue Hotel in Chicago, IL. Lance Berry, Chief Financial Officer, will present at 11:40 a.m. Central Time. A live audio webcast of the conference ... 
Printer Friendly Version
03/04/13Wright Medical Group, Inc. to Participate in Barclays Global Healthcare Conference
Wednesday, March 13, 2013 at 10:15 a.m. Eastern Time ARLINGTON, Tenn.--(BUSINESS WIRE)--Mar. 4, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) announced today that it will be participating in the Barclays Global Healthcare Conference on Wednesday, March 13, 2013, at the Loews Miami Beach Hotel in Miami Beach, Florida. Robert Palmisano, President and Chief Executive Officer, will present at 10:15 a.m. Eastern Time. A live audi... 
Printer Friendly Version
03/01/13Wright Medical Group, Inc. Completes Acquisition of BioMimetic Therapeutics, Inc.
ARLINGTON, Tenn.--(BUSINESS WIRE)--Mar. 1, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it has completed its acquisition of BioMimetic Therapeutics, Inc. The transaction combines BioMimetic's breakthrough biologics platform and pipeline with Wright's established sales force and product portfolio, to further accelerate growth opportunities in Wright's Extremities business. Wright previously announced plans on November 19, 2012 to acquire BioMimetic Therapeutics, Inc. fo... 
Printer Friendly Version
02/21/13Tornier Names David H. Mowry President and Chief Executive Officer
February 21, 2013AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that its Board of Directors has appointed David H. Mowry as President and Chief Executive Officer, effective immediately. Sean D. Carney, Chairman of Tornier, commented, "Dave has demonstrated an intensity and concentration in executing on the key initiatives in his charge since joining Tornier in... 
Printer Friendly Version
02/21/13Tornier Reports Fourth Quarter and Fiscal Year 2012 Results and Provides 2013 Outlook
February 21, 2013OrthoHelix Acquisition Closed and Integration Proceeding Smoothly Adjusted EBITDA Margin Improves for both Fourth Quarter and Full Year AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported today its financial results for the fourth quarter and fiscal year ended December 30, 2012. Revenue for the fourth quart... 
Printer Friendly Version
02/21/13Wright Medical Group, Inc. Reports 2012 Fourth Quarter and Full-Year Financial Results and Provides 2013 Guidance
Significant Progress Made in 2012 to Transform Business and Maximize Foot and Ankle Opportunity Fourth Quarter Global Foot and Ankle Net Sales Increase 20% As Reported and 20% Constant Currency Full-Year 2012 Net Cash Flow from Operating Activities of $68.8 Million and Free Cash Flow of $49.5 Million ARLINGTON, Tenn.--(BUSINESS WIRE)--Feb. 21, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) reported financial results for its fourth quarter ended December 31, 2012 and provided 2013 g... 
Printer Friendly Version
02/11/13Tornier to Present at the 2013 RBC Capital Markets Global Healthcare Conference
February 11, 2013AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's Interim President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will be presenting at the 2013 RBC Capital Markets Global Healthcare Conference. The Company's presentation is scheduled for Wednesday, February 27, at 2:30 p... 
Printer Friendly Version
01/30/13Wright Medical Group, Inc. to Host Fourth Quarter 2012 Earnings Conference Call
Thursday, February 21, 2013 at 3:30 p.m. Central / 4:30 p.m. Eastern ARLINGTON, Tenn.--(BUSINESS WIRE)--Jan. 30, 2013-- Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it will host a conference call on Thursday, February 21, 2013 at 3:30 p.m. Central Time to discuss the Company’s operating results for its fourth quarter ended December 31, 2012. Operating results will be released at 3:00 p.m. Central Time that day. ... 
Printer Friendly Version
01/22/13Tornier Announces 2012 Fourth Quarter and Full Year Conference Call
January 22, 2013AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the fourth quarter and full year ended December 31, 2012 after the market close on Thursday, February 21, 2013. The Company also announced that it will host an investor conference call to discuss the results on the same day at 4:30 PM Eastern Time. Tornier... 
Printer Friendly Version
01/07/13Tornier Reiterates Fourth Quarter and Full Year 2012 Revenue Guidance
January 7, 2013Full Financial Results Available on February 21, 2013; Company to Present at J.P. Morgan Healthcare Conference on January 7, 2013 AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reiterated today that it expects revenue for the fourth quarter and full year of 2012 to be in the range $75.8 to $78.8 million and $274.0 to $277.0 million, respectively, consistent... 
Printer Friendly Version